Invesaro

Stocks TNDM Earnings

Earnings

Tandem Diabetes Care Inc (TNDM) earnings

Quarterly results of Tandem Diabetes Care Inc as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when TNDM files with the SEC.

Next earnings date

Tandem Diabetes Care Inc is expected to report around February 18, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Tandem Diabetes Care Inc reported revenue of $283.7M (+13.8% on the same quarter a year earlier) and a net loss of $7.1M.

Diluted earnings per share were -$0.10.

Filed with the SEC on November 5, 2026.

Revenue by quarter
Q4 24: $282.6M $282.6M Q4 24Q1 25: $234.4M $234.4M Q1 25Q2 25: $240.7M $240.7M Q2 25Q3 25: $249.3M $249.3M Q3 25Q4 25: $290.4M $290.4M Q4 25Q1 26: $247.2M $247.2M Q1 26Q2 26: $254.6M $254.6M Q2 26Q3 26: $283.7M $283.7M Q3 26
Net income by quarter
Q4 24: $755K $755K Q4 24Q1 25: -$130.6M -$130.6M Q1 25Q2 25: -$52.4M -$52.4M Q2 25Q3 25: -$21.2M -$21.2M Q3 25Q4 25: -$589K -$589K Q4 25Q1 26: -$20.4M -$20.4M Q1 26Q2 26: -$21.2M -$21.2M Q2 26Q3 26: -$7.1M -$7.1M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026$283.7M+13.8%-$7.1M-$0.10
Q2 FY2026June 30, 2026$254.6M+5.8%-$21.2M-$0.31
Q1 FY2026March 31, 2026$247.2M+5.5%-$20.4M-$0.30
Q4 FY2025December 31, 2025$290.4M+2.7%-$589K-$0.01
Q3 FY2025September 30, 2025$249.3M--$21.2M-$0.31
Q2 FY2025June 30, 2025$240.7M--$52.4M-$0.78
Q1 FY2025March 31, 2025$234.4M--$130.6M-$1.97
Q4 FY2024December 31, 2024$282.6M-$755K$0.01

Results filings

When is Tandem Diabetes Care Inc's next earnings date?

Tandem Diabetes Care Inc is expected to report around February 18, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Tandem Diabetes Care Inc's latest quarterly results?

For Q3 FY2026, which ended September 30, 2026, Tandem Diabetes Care Inc reported revenue of $283.7M and a net loss of $7.1M. The figures come from its filing with the SEC.

Is Tandem Diabetes Care Inc's revenue growing?

Revenue in Q3 FY2026 was $283.7M, up 13.8% from $249.3M in the same quarter a year earlier.

Get an email when TNDM reports

Follow TNDM and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when TNDM files with the SEC.

Source: quarterly figures Tandem Diabetes Care Inc tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Tandem Diabetes Care Inc